Key result
PFA achieves successful pulmonary vein isolation without causing deep brain stimulator interference.
Why the study?
Established ablation energy sources are not recommended in patients with implanted neurostimulation devices due to device interference risk, and data on pulsed field ablation in this population are lacking.
Does pulsed field ablation allow safe pulmonary vein isolation without device interference in a patient with an implanted deep brain stimulator?
Case Report (n=1)
No
Does pulsed field ablation allow safe pulmonary vein isolation without device interference in a patient with an implanted deep brain stimulator?
This first reported case demonstrates that pulsed field ablation can be safely performed for pulmonary vein isolation in a patient with an implanted deep brain stimulator when appropriate peri-procedural precautions, such as temporary device deactivation, are taken.
May support cautious pulsed field ablation use with deep brain stimulators after deactivation; leaves open need for larger safety studies before routine adoption.
Background Pulmonary vein isolation for atrial fibrillation (AF) in patients with implanted neurostimulation devices is challenging, as established energy sources such as radiofrequency (RF) ablation are generally not recommended in these patients due to the risk of device interference. Pulsed field ablation (PFA) for AF offers relative myocardial selectivity and a potentially improved safety profile. However, data on its use in patients with implanted neurostimulation devices are lacking. Case summary A 66-year-old woman with paroxysmal AF was referred to our center for catheter ablation. Years earlier, a deep brain stimulator (DBS) had been implanted to control severe fasciculations. As RF ablation is not recommended in such patients and given the patient’s multiple comorbidities, a single-shot ablation strategy was chosen. After selective pulmonary vein angiography revealed a large left common pulmonary vein (LCPV), PFA using a pentaspline catheter was selected, as this approach allows effective treatment of a LCPV with short procedure times and a favorable safety profile. The DBS was deactivated prior to the procedure and ablation was performed without complications. After the procedure, the DBS was reactivated and showed no evidence of device malfunction. Discussion This is the first reported case that demonstrates the feasibility of PFA in a patient with an implanted DBS. Temporary deactivation of the neurostimulation device and careful multidisciplinary planning allowed successful ablation without device dysfunction or interference. These findings suggest that, with appropriate precautions, PFA may represent a viable ablation strategy in selected patients with implanted neurostimulation systems.
No takes yet. Share an insight, caveat, or question.
Marx et al. (2026) conducted a case report in Paroxysmal atrial fibrillation with implanted deep brain stimulator (n=1). Pulsed field ablation (PFA) was evaluated on Procedural success and device interference or malfunction. Pulsed field ablation was successfully performed in a patient with an implanted deep brain stimulator without causing device interference or malfunction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: